FDA Adverse Event Injury Summary report: N

ENDOTAK RELIANCE

MDR report key: 1951451 · Received January 6, 2011

Report

Report Number
2124215-2010-22953
Event Type
Injury
Date Received
January 6, 2011
Date of Event
September 13, 2010
Report Date
November 24, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVY
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE LEAD WAS CAPPED AND SURGICALLY ABANDONED. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE DEFIBRILLATION LEAD EXHIBITED AN INCREASE IN PACING IMPEDANCE MEASUREMENTS, INCLUDING MEASUREMENTS GREATER THAN 2000 OHMS. INTERMITTENT CAPTURE WAS ALSO OBSERVED. AN INVASIVE PROCEDURE WAS PERFORMED. THE LEAD WAS CAPPED AND REPLACED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ENDOTAK RELIANCE IMPLANTABLE LEAD NVY CPI - DEL CARIBE 0174

Patients

Seq Age Sex Outcome Treatment
1 62 YR Required Intervention T177| 0174